Abstract
Molecular medicine is the application of the principles of molecular biology to the theory and practice of medicine. Although it is most modern, its evolution can be viewed in the larger context of the development of scientific medicine and its quest for the fundamental explanation of disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Huxley AF NR. Structural changes in muscle during contraction. Nature. 1954:971–973.
Huxley HE HJ. Changes in the cross-striations of muscle during contraction and stretch and their functional interpretation. Nature. 1954; 173:973–976.
Patterson SW PH, Starling HE. The regulation of the heart beat. J Physiol. 1914;48:465–513.
Pauling L. Sickle ell anemia, a molecular disease. Science. 1949;110:543–548.
Anversa P, Ricci R, Olivetti G. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review. J Am Coll Cardiol. 1986;7:1140–9.
Pauling L CR, Branson HR. The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain. Proc Nat Acad Sci USA. 1951;37:205–211.
Pauling L CR. Configuration of polypeptide chains with favored orientations around single bonds: two new pleated sheets. Proc Nat Acad Sci USA. 1951;37:729–740.
Anfinsen CB. Principles that govern the folding of protein chains. Science. 1973; 181:223–30.
Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol. 1997;80:15L–25L.
.Mittmann C ET, Scholz H. Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovascular Research. 1998;39:267–275.
Bristow M. Why does the myocardium fail? Insights from basic science. Lancet. 1998;352:8–14.
Taeschler M BR. Some properties of contractile protein of the heart as studied on the extracted heart muscle preparation. Circulation Res. 1953;1:129–134.
Elzinga M, Collins JH, Kuehl WM, Adelstein RS. Complete amino-acid sequence of actin of rabbit skeletal muscle. Proc Natl Acad Sci USA. 1973;70:2687–91.
Holmes KC, Popp D, Gebhard W, Kabsch W. Atomic model of the actin filament [see comments]. Nature. 1990;347:44–9.
Svent-Gyorgyi A. Contraction in the heart muscle fibre. Bull NY Acad Med. 1952;28:3–10.
Gordon AM HA, Julian FT. The variations in isometric tension with sarcomere length in vertebrate muscle fibers. JPhysiol. 1966; 184:170–192.
Dominguez R, Freyzon Y, Trybus KM, Cohen C. Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: visualization of the pre-power stroke state. Cell. 1998;94:559–71.
Winkelmann DA, Mekeel H, Rayment I. Packing analysis of crystalline myosin subfragment-1. Implications for the size and shape of the myosin head. J Mol Biol. 1985; 181:487–501.
Tokunaga M, Sutoh K, Toyoshima C, Wakabayashi T. Location of the ATPase site of myosin determined by three-dimensional electron microscopy [published erratum appears in Nature 1987 Nov 26-Dec 2;330(6146):404]. Nature. 1987;329:635–8.
Yamamoto K. Binding manner of actin to the lysine-rich sequence of myosin subfragment 1 in the presence and absence of ATP. Biochemistry. 1989;28:5573–7.
Botts J, Thomason JF, Morales MF. On the origin and transmission of force in actomyosin subfragment 1. Proc Natl Acad Sci U S A. 1989;86:2204–8.
Gulick AM, Rayment I. Structural studies on myosin II: communication between distant protein domains. Bioessays. 1997;19:561–9.
Fisher AJ, Smith CA, Thoden J, Smith R, Sutoh K, Holden HM, Rayment I. Structural studies of myosin:nucleotide complexes: a revised model for the molecular basis of muscle contraction. Biophys J. 1995;68:19S–26S; discussion 27S-28S.
Rayment I, Holden HM, Whittaker M, Yohn CB, Lorenz M, Holmes KC, Milligan RA. Structure of the actin-myosin complex and its implications for muscle contraction [see comments]. Science. 1993;261:58–65.
Beadle GW, Tatum, E.L. Genetic control of biochemical reactions in Neurospora. Proc Natl Acad Sci. 1941;27:499–506.
Watson JD, Crick, F.H.C. A structure for deoxyribonucleic acid. Nature. 1953;171:737–738.
Towbin JA. Molecular genetic aspects of cardiomyopathy. Biochemical Medicine and Metabolic Biology. 1993;49:285–320.
Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE, Seidman JG. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999–1006.
Vikstrom KL, Leinwand LA. Contractile protein mutations and heart disease. Curr Opin Cell Biol. 1996;8:97–105.
Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy [see comments]. N Engl J Med. 1992;326:1108–14.
Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA. 1995;92:3864–8.
McKenna WJ, Coccolo F, Elliott PM. Genes and disease expression in hypertrophic cardiomyopathy [In Process Citation]. Lancet. 1998;352:1162–3.
Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science. 1998;280:750–2.
Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy [see comments]. Circulation. 1997;95:2434–40.
Spyrou N, Philpot J, Foale R, Camici PG, Muntoni F. Evidence of left ventricular dysfunction in children with merosin-deficient congenital muscular dystrophy. Am Heart J. 1998;136:474–6.
Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339:900–5.
Abbott BC, Wilke, D.R. The relation between velocity of shortening and the tension-length curve of skeletal muscle. J Physiol. 1953;120:214–223.
Abbott BC, Mommaerts, W.F.H.M. A study of inotropic mechanisms in the papillary muscle preparation. J Gen Physiol. 1959;42:533–551.
Alpert NR, Mulieri LA, Litten RZ. Functional significance of altered myosin adenosine triphosphatase activity in enlarged hearts. Am J Cardiol. 1979;44:946–53.
Barany M, Conover TE, Schliselfeld LH, Gaetjens E, Goffart M. Relation of properties of isolated myosin to those of intact muscles of the cat and sloth. Eur J Biochem. 1967;2:156–64.
Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest. 1989;84:1693–700.
Saez LJ, Gianola KM, McNally EM, Feghali R, Eddy R, Shows TB, Leinwand LA. Human cardiac myosin heavy chain genes and their linkage in the genome. Nucleic Acids Res. 1987;15:5443–59.
Kurabayashi M, Tsuchimochi H, Komuro I, Takaku F, Yazaki Y. Molecular cloning and characterization of human cardiac alpha-and beta-form myosin heavy chain complementary DNA clones. Regulation of expression during development and pressure overload in human atrium. J Clin Invest. 1988;82:524–31.
Nakao K, Minobe W, Roden R, Bristow MR, Leinwand LA. Myosin heavy chain gene expression in human heart failure. J Clin Invest. 1997;100:2362–70.
Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure [see comments]. N Engl J Med. 1990;322:100–10.
Jacob F, Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J Mol Biol. 1961;3:318–356.
Hefti MA, Harder BA, Eppenberger HM, Schaub MC. Signaling pathways in cardiac myocyte hypertrophy. J Mol Cell Cardiol. 1997;29:2873–92.
Anversa P, Olivetti G, Melissari M, Loud AV. Stereological measurement of cellular and subcellular hypertrophy and hyperplasia in the papillary muscle of adult rat. J Mol Cell Cardiol. 1980;12:781–95.
Bristow MR, Gilbert, E.M., Lowes, B.D., Minobe WA, Shakar, S.F., Quaife, R.A., Abraham, W.T. Changes in gene expression asociated with b-blocker-related improvements in ventricular systolic function. Circulation. 1997;96:I–92.
Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247–59.
Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;97:2891–7.
Glennon PE, Kaddoura S, Sale EM, Sale GJ, Fuller SJ, Sugden PH. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. Circ Res. 1996;78:954–61.
Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. J BiolChem. 1992;267:10551–60.
Kudoh S, Komuro I, Hiroi Y, Zou Y, Harada K, Sugaya T, Takekoshi N, Murakami K, Kadowaki T, Yazaki Y. Mechanical stretch induces hypertrophie responses in cardiac myocytes of angiotensin II type la receptor knockout mice. J Biol Chem. 1998;273:24037–43.
Wollert KC, Taga T, Saito M, Narazaki M, Kishimoto T, Glembotski CC, Vernallis AB, Heath JK, Pennica D, Wood WI, Chien KR. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gpl30/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem. 1996;271:9535–45.
Heinrich PC, Behrmann I, G Ml-N, Schaper F, Graeve L. Interleukin-6-type cytokine signalling through the gpl30/Jak/STAT pathwayl. Biochem J. 1998;334:297–314.
Calderone A, Takahashi N, Izzo NJ, Jr., Thaik CM, Colucci WS. Pressure-and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995;92:2385–90.
Erdmann J, Hassfeld S, Kaliisch H, Fleck E, Regitz-Zagrosek V. Cloning and characterization of the 5’-flanking region of the human cardiotrophin-1 gene. Biochem Biophys Res Commun. 1998;244:494–7.
.Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA. Apoptosis in myocytes in end-stage heart failure [see comments]. N Engl J Med. 1996;335:1182–9.
Dec GW, Fuster V. Idiopathic dilated cardiomyopathy [see comments]. N Engl J Med. 1994;331:1564–75.
Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336:1131–41.
Chandrasekar B, Melby PC, Pennica D, Freeman GL. Overexpression of cardiotrophin-1 and gpl30 during experimental acute Chagasic cardiomyopathy. Immunol Lett. 1998;61:89–95.
Barbara G, Di Lorenzo G, Grisorio B, Barbarini G. Incidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive Patients. N Engl J Med. 1998;339:1093–1099.
Garner I, Sassoon D, Vandekerckhove J, Alonso S, Buckingham ME. A developmental study of the abnormal expression of alpha-cardiac and alpha-skeletal actins in the striated muscle of a mutant mouse. Dev Biol. 1989; 134:236–45.
Buckingham ME. Actin and myosin multigene families: their expression during the formation of skeletal muscle. Essays Biochem. 1985;20:77–109.
Katz AM. The cardiomyopathy of overload: an unnatural growth response in the hypertrophied heart. Ann Intern Med. 1994;121:363–71.
Takahashi T, Allen PD, Izumo S. Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene. Circ Res. 1992;71:9–17.
Cornelius T, Holmer SR, Müller FU, Riegger GA, Schunkert H. Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload. Hypertension. 1997;30:1348–55.
Sack MN, Disch DL, Rockman HA, Kelly DP. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophie growth program. Proc Natl Acad Sci USA. 1997;94:6438–43.
Yue P, Long CS, Austin R, Chang KC, Simpson PC, Massie BM. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype [In Process Citation]. J Mol Cell Cardiol. 1998;30:1615–30.
Boxer LM, Miwa T, Gustafson TA, Kedes L. Identification and characterization of a factor that binds to two human sarcomeric actin promoters. J Biol Chem. 1989;264:1284–92.
Navankasattusas S, Sawadogo M, van Bilsen M, Dang CV, Chien KR. The basic helix-loop-helix protein upstream stimulating factor regulates the cardiac ventricular myosin light-chain 2 gene via independent cis regulatory elements. Mol Cell Biol. 1994; 14:7331–9.
Hasegawa K, Lee SJ, Jobe SM, Markham BE, Kitsis RN. cis-Acting sequences that mediate induction of beta-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction [see comments]. Circulation. 1997;96:3943–53.
Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215–28.
Zilberman A, Dave V, Miano J, Olson EN, Periasamy M. Evolutionarily conserved promoter region containing CArG*-like elements is crucial for smooth muscle myosin heavy chain gene expression. Circ Res. 1998;82:566–75.
Schiaffino S, Samuel JL, Sassoon D, Lompre AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K. Nonsynchronous accumulation of alpha-skeletal actin and beta-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 1989;64:937–48.
Xiao Q, Ojamaa K. Regulation of cardiac alpha-myosin heavy chain gene transcription by a contractile-responsive E-box binding protein. J Mol Cell Cardiol. 1998;30:87–95.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Kluwer Academic Publishers
About this chapter
Cite this chapter
Sanders, M.R. (1999). Introduction to Molecular Medicine: A Contemporary View of Heart Failure. In: Sanders, M., Kostis, J.B. (eds) Molecular Cardiology in Clinical Practice. Basic Science for the Cardiologist, vol 2. Springer, Boston, MA. https://doi.org/10.1007/978-0-585-38141-1_1
Download citation
DOI: https://doi.org/10.1007/978-0-585-38141-1_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-8602-5
Online ISBN: 978-0-585-38141-1
eBook Packages: Springer Book Archive